Foresee Biosystems, your solution to chronic cardiac safety
Foresee biosystems SRL is an italian start-up focused on designing and marketing innovative platforms for in-vitro cardiac electrophysiology and the prediction of toxicological outcomes of a drug or chemical on cardiac cellular models. Combining high quality data from robust in vitro Micro Electrode Array (MEA) assays and a patented LASER technology, our products allow for the recording of intracellular action potentials over many weeks, enabling long-term assessment of cardiotoxicology.